Dr Lee Dong-ki, founder and CEO
Dr Lee Dong-ki, founder and CEO

OliX Pharmaceuticals develops ribonucleotide technologies for untreatable diseases

  • With key leadership in the US subsidiary comprising Asians, OliX hopes to have a strong future relationship with therapeutic companies in the Asian territory

Dr Lee Dong-ki, founder and CEO
Dr Lee Dong-ki, founder and CEO
READ FULL ARTICLE